Cargando…
US life expectancy stalls due to cardiovascular disease, not drug deaths
After decades of robust growth, the rise in US life expectancy stalled after 2010. Explanations for the stall have focused on rising drug-related deaths. Here we show that a stagnating decline in cardiovascular disease (CVD) mortality was the main culprit, outpacing and overshadowing the effects of...
Autores principales: | Mehta, Neil K., Abrams, Leah R., Myrskylä, Mikko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132127/ https://www.ncbi.nlm.nih.gov/pubmed/32179670 http://dx.doi.org/10.1073/pnas.1920391117 |
Ejemplares similares
-
The growing rural–urban divide in US life expectancy: contribution of cardiovascular disease and other major causes of death
por: Abrams, Leah R, et al.
Publicado: (2021) -
Cardiovascular Mortality Gap Between the United States and Other High Life Expectancy Countries in 2000–2016
por: Acosta, Enrique, et al.
Publicado: (2022) -
The “double jeopardy” of midlife and old age mortality trends in the United States
por: Abrams, Leah R., et al.
Publicado: (2023) -
An Introduction to the Supplemental Issue on Why Does Health in the US Continue to Lag Behind
por: Mehta, Neil K, et al.
Publicado: (2022) -
Cohort Trends in Working Life Expectancies at Age 50 in the United States: A Register-Based Study Using Social Security Administration Data
por: Dudel, Christian, et al.
Publicado: (2020)